HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance
HIV大分子相互作用及其对病毒耐药性进化的影响
基本信息
- 批准号:8641747
- 负责人:
- 金额:$ 5.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnti-HIV AgentsBehaviorBinding SitesBiochemistryBiologicalChemicalsChromatinComplexComputational BiologyComputing MethodologiesCrystallizationCrystallographyDNA IntegrationDNA biosynthesisDataDrug DesignDrug TargetingDrug resistanceEnvironmentEnzymesEvolutionGaggingGoalsHIVHIV IntegraseHIV ProteaseHIV-1HumanKineticsKnowledgeLife Cycle StagesLinkMembraneMethodologyMethodsModelingMolecular BiologyMolecular StructureMutationNucleic AcidsPeptide HydrolasesPlayPolyproteinsPredispositionProcessPropertyProteinsRNARNA-Directed DNA PolymeraseResearch PersonnelResistanceRibonuclease HRoleSerial PassageSiteStructural ModelsStructureSynthesis ChemistrySystemTestingTherapeuticThermodynamicsTransfer RNAViralViral PhysiologyVirionbasechemical synthesiscombatfitnessflexibilitygag Gene Productsimprovedinhibitor/antagonistinsightknowledge basemacromoleculemutantnovelpol Gene Productsprotein complexresistance mutationscreeningsmall moleculetherapeutic targetvirologyvirtual
项目摘要
DESCRIPTION (provided by applicant): We have formed the HIVE Center to characterize at the atomic level the structural and dynamic relationships between interacting macromolecules in the HIV life cycle. We will focus on interactions of the major HIV enzymes with their partners and effectors since they encompass key processes in the viral life cycle and as existing drug targets provide a rich base of structural, biological and evolutionary data that will serve to infom our goals. We will explore resistance evolution in HIV as an opportune platform upon which to characterize the dynamic relationships between interacting macromolecular structures at the atomic level. The HIVE Center comprises a group of investigators with considerable expertise in HIV crystallography, virology, molecular biology, synthetic chemistry and computational biology. We will study the mechanistic implications of viral macromolecular interactions and dynamics and its broader impacts of the evolution of drug resistance. The goals of this center are to answer the following fundamental questions with our studies: 1. How do structures of the HIV polyprotein precursors direct assembly, maturation, and replication? 2. What novel HIV-Host interactions drive DNA replication and integration? 3. How does dynamics impact viral fitness and how can it be exploited for therapeutic targeting? 4. What are the structural and dynamic consequences of resistance mutations in the HIV life cycle, and how? In order to carry out these studies we will develop, improve and apply the following Technical Methods for: 1. Efficient expression, crystallization, and atomic level structure determination of HIV polyprotein and nucleic acid complexes. 2. Determination and characterization of novel binding sites and their impact on the dynamic and evolutionary properties of HIV protein complexes. 3. Computational methods to characterize the interactions, dynamics and evolution of HIV protein complexes at multiple spatial and temporal scales. Our approach is significant both for the promise of new structural insights into the interdependence of viral mechanisms, but also for the direct potential for new drug design methodologies and therapeutic strategies.
描述(由申请人提供):我们成立了HIVE中心,在原子水平上表征HIV生命周期中相互作用的大分子之间的结构和动态关系。我们将重点关注主要HIV酶与其伙伴和效应物的相互作用,因为它们包含病毒生命周期中的关键过程,并且现有的药物靶点提供了丰富的结构、生物学和进化数据基础,将有助于为我们的目标提供信息。我们将探索艾滋病病毒的耐药性进化,作为一个合适的平台,在原子水平上表征相互作用的大分子结构之间的动态关系。HIVE中心由一组在HIV晶体学、病毒学、分子生物学、合成化学和计算生物学方面具有相当专业知识的研究人员组成。我们将研究病毒大分子相互作用和动力学的机制含义及其对耐药性进化的更广泛影响。本中心的目标是通过我们的研究来回答以下基本问题:HIV多蛋白前体的结构如何指导组装、成熟和复制?2. 什么新的hiv -宿主相互作用驱动DNA复制和整合?3. 动力学如何影响病毒适应度以及如何将其用于靶向治疗?4. 耐药突变在HIV生命周期中的结构和动态后果是什么?如何造成的?为了开展这些研究,我们将开发、改进和应用以下技术方法:HIV多蛋白和核酸复合物的高效表达、结晶和原子水平结构测定。2. 新结合位点的测定和表征及其对HIV蛋白复合物动态和进化特性的影响。3. 描述HIV蛋白复合物在多个时空尺度上的相互作用、动态和进化的计算方法。我们的方法不仅对病毒机制相互依赖的新结构见解有重要意义,而且对新药设计方法和治疗策略也有直接的潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ARTHUR J. OLSON其他文献
ARTHUR J. OLSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ARTHUR J. OLSON', 18)}}的其他基金
Discovery and use of chemical probes through SuFEx chemistry, computational design and predictive modeling
通过 SuFEx 化学、计算设计和预测建模发现和使用化学探针
- 批准号:
10242910 - 财政年份:2012
- 资助金额:
$ 5.62万 - 项目类别:
Discovery and use of chemical probes through SuFEx chemistry, computational design and predictive modeling
通过 SuFEx 化学、计算设计和预测建模发现和使用化学探针
- 批准号:
10363027 - 财政年份:2012
- 资助金额:
$ 5.62万 - 项目类别:
HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance
HIV大分子相互作用及其对病毒耐药性进化的影响
- 批准号:
8537483 - 财政年份:2012
- 资助金额:
$ 5.62万 - 项目类别:
HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance
HIV大分子相互作用及其对病毒耐药性进化的影响
- 批准号:
8411426 - 财政年份:2012
- 资助金额:
$ 5.62万 - 项目类别:
HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance
HIV大分子相互作用及其对病毒耐药性进化的影响
- 批准号:
8731926 - 财政年份:2012
- 资助金额:
$ 5.62万 - 项目类别:
HIV Macromolecular Interactions and Impact on Viral Evolution of Drug Resistance
HIV大分子相互作用及其对病毒耐药性进化的影响
- 批准号:
8920604 - 财政年份:2012
- 资助金额:
$ 5.62万 - 项目类别:
SMALL MOLECULES REGULATING PROTEIN-PROTEIN INTERACTIONS IN CANCER
调节癌症中蛋白质-蛋白质相互作用的小分子
- 批准号:
8362797 - 财政年份:2011
- 资助金额:
$ 5.62万 - 项目类别:
PRESERVING VISION IN INHERITED AND AGE-RELATED RETINAL DEGENERATIONS
保护遗传性和年龄相关性视网膜变性患者的视力
- 批准号:
8362798 - 财政年份:2011
- 资助金额:
$ 5.62万 - 项目类别:
Resistance Driven Structural Design for HIV Therapies
HIV 疗法的阻力驱动结构设计
- 批准号:
7931497 - 财政年份:2009
- 资助金额:
$ 5.62万 - 项目类别:
相似海外基金
Development of anti-HIV agents with dual mechanisms of actions based on triterpenoids as drug discovery templates
以三萜类化合物为药物发现模板,开发具有双重作用机制的抗 HIV 药物
- 批准号:
15K07998 - 财政年份:2015
- 资助金额:
$ 5.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of anti-HIV agents targeting weak points of viral replication mechanism
针对病毒复制机制的弱点开发抗HIV药物
- 批准号:
26670053 - 财政年份:2014
- 资助金额:
$ 5.62万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Structure activity and structure property relationships for novel anti-HIV agents
新型抗HIV药物的结构活性和结构性质关系
- 批准号:
8466077 - 财政年份:2012
- 资助金额:
$ 5.62万 - 项目类别:
Structure activity and structure property relationships for novel anti-HIV agents
新型抗HIV药物的结构活性和结构性质关系
- 批准号:
8777085 - 财政年份:2012
- 资助金额:
$ 5.62万 - 项目类别:
Development of anti-HIV agents that exert synergism with host immune pressure
开发与宿主免疫压力发挥协同作用的抗HIV药物
- 批准号:
24390254 - 财政年份:2012
- 资助金额:
$ 5.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Design and synthesis of anti-HIV agents that inhibit the Pr55Gag membrane localization
抑制 Pr55Gag 膜定位的抗 HIV 药物的设计和合成
- 批准号:
24790124 - 财政年份:2012
- 资助金额:
$ 5.62万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Structure activity and structure property relationships for novel anti-HIV agents
新型抗HIV药物的结构活性和结构性质关系
- 批准号:
8588784 - 财政年份:2012
- 资助金额:
$ 5.62万 - 项目类别:
Developing host defense peptides as novel anti-HIV agents
开发宿主防御肽作为新型抗 HIV 药物
- 批准号:
230278 - 财政年份:2011
- 资助金额:
$ 5.62万 - 项目类别:
Fellowship Programs
Design and synthesis of anti-HIV agents that inhibit the Vif-mediated proteasome degradation of APOBEC3G
设计和合成抑制 Vif 介导的 APOBEC3G 蛋白酶体降解的抗 HIV 药物
- 批准号:
22659024 - 财政年份:2010
- 资助金额:
$ 5.62万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of anti-HIV agents using chemical genomics based on viral self-regulation mechanism
基于病毒自我调节机制的化学基因组学抗HIV药物的开发
- 批准号:
22659021 - 财政年份:2010
- 资助金额:
$ 5.62万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research














{{item.name}}会员




